Evidence map›Paper›PMID 27742242›Full record

ArticleJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography2017

Impact of Right Ventricular Dysfunction and Tricuspid Regurgitation on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.

Lorin Arie Schwartz, Zach Rozenbaum, Ehab Ghantous, Judith Kramarz, Simon Biner, Michael Ghermezi, Jason Shimiaie, Ariel Finkelstein, Shmuel Banai, Galit Aviram and 3 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07623083 (Evaluation of a Treatment Algorithm for the Management of TAVI Patients With Significant Concomitant Mitral or Tricuspid Regurgitation), which is not on this map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07623083 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of a Treatment Algorithm for the Management of TAVI Patients With Significant Concomitant Mitral or Tricuspid Regurgitation

TypeobservationalSponsorJosep Rodes-CabauRan2026 to 2034Enrolled300ConditionsAortic Stenosis, Mitral Regurgitation, Tricuspid Regurgitation, Transcatheter Aortic Valve Implantation (TAVI)
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Right ventricular to pulmonary artery coupling in patients with different types of aortic stenosis undergoing TAVI.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Multiple Valvular Heart Disease in the Transcatheter Era: A State-of-the-Art Review.Structural heart : the journal of the Heart Team · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Lorin Arie SchwartzDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Zach RozenbaumDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Ehab GhantousDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Judith KramarzDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Simon BinerDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Michael GhermeziDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Jason ShimiaieDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Ariel FinkelsteinDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Shmuel BanaiDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Galit AviramDivision of Radiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Meirav IngbirDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Gad KerenDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.
Yan TopilskyDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: topilskyyan@gmail.com.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRight ventricular (RV) dysfunction and tricuspid regurgitation (TR) may coexist with aortic stenosis. The aim of this study was to assess the association between RV dysfunction, TR, associated comorbidities, and outcomes following transcatheter aortic valve replacement (TAVR).

methodsA retrospective analysis was conducted of baseline and 6-month clinical and echocardiographic parameters, including TR grade, RV size (grade, end-diastolic and end-systolic areas, annular diameter), and function (grade, tricuspid annular plane systolic excursion [TAPSE], fractional area change, Tei index), in 519 consecutive TAVR patients.

resultsThe prevalence of moderate or greater TR was 11% (n = 59). Although TR was associated with increased mortality (P = .02) in unadjusted analysis, it did not demonstrate an independent association with outcome when adjusted for RV dysfunction (TAPSE; P = .30) or multiple clinical parameters (P ≥ .20). RV parameters associated with poor outcomes included TAPSE (P = .006) and Tei index (P = .005). TAPSE was associated with lower survival even when adjusted for TR (P = .009) and all clinical parameters (P = .01). Persistence of moderate or greater TR 6 months after TAVR seemed to be associated with lower survival (P = .02), even when adjusted for clinical and RV parameters (P = .07).

conclusionsTR in association with aortic stenosis is frequently progressive despite TAVR but is not independently associated with outcomes. RV function is a stronger driver of adverse outcomes compared with TR itself, and RV quantitative rather than qualitative evaluation is the key to stratify these patients.

Indexed as

Aged, 80 and overAortic Valve StenosisCausalityComorbidityEchocardiographyFemaleHumansIsraelMalePrevalencePrognosisRetrospective StudiesRisk FactorsSurvival RateTranscatheter Aortic Valve ReplacementTreatment OutcomeAortic stenosisPrognosisTranscatheter aortic valve replacementTricuspid annular plane systolic excursionTricuspid regurgitation

Identifiers

PMID27742242
OpenAlexW2531084087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.